_:nb12966479a74441c94cb5fbad250f846xb0
<http://schema.org/abstract>
"<p>AbbVie and Calico Life Sciences—a biotech firm focused on age-related diseases and funded by Alphabet, Google’s parent company—will extend their research partnership a second time. The two firms, which began collaborating in 2014, have advanced three immuno-oncology and neurodegeneration programs to clinical trials. More than 20 early-stage programs are in the works. Each firm will commit an additional $500 million to the effort, and Calico will helm research and early development until 2025.</p>"
<https://cen.acs.org/pharmaceuticals/drug-development/AbbVie-Calico-extend-collaboration-1/99/i28?sc=230901_cenymal_eng_slot3_cen>